H Urbańska-Ryś

Plasmablastic lymphoma in a patient with chronic lymphocytic leukemia heavily pretreated with cladribine (2‐CdA): an unusual variant of Richter's syndrome

Tadeusz Robak, H Urbańska-Ryś, Bogusława Strzelecka et al. · European Journal Of Haematology · 2001 · 76 citations

Medicine, Hematology, Oncology +14

Polymorphisms and haplotypes in the multidrug resistance 1 gene (MDR1/ABCB1) and risk of multiple myeloma

Krzysztof Jamroziak, Ewa Balcerczak, Sylwester Piaskowski et al. · Leukemia Research · 2008 · 67 citations

Life Sciences, Genetics, Molecular Genetics +14

Circulating IL‐6‐type cytokines and sIL‐6R in patients with multiple myeloma

Agnieszka Wierzbowska, H Urbańska-Ryś, Tadeusz Robak · British Journal of Haematology · 1999 · 49 citations · Full text

Medicine, Hematology, Immunology +15

Circulating VEGF and its soluble receptors sVEGFR-1 and sVEGFR-2 in patients with acute leukemia.

Agnieszka Wierzbowska, Tadeusz Robak, Agata Wrzesień‐Kuś et al. · PubMed · 2004 · 42 citations

Medicine, Hematology, Oncology +16

Relationship between circulating interleukin-10 (IL-10) with interleukin-6 (IL-6) type cytokines (IL-6, interleukin-11 (IL-11), oncostatin M (OSM)) and soluble interleukin-6 (IL-6) receptor (sIL-6R) in patients with multiple myeloma.

H Urbańska-Ryś, A Wiersbowska, H Stępień et al. · PubMed · 2000 · 42 citations

Medicine, Hematology, Immunology +13